BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 322087)

  • 1. [Value of anticonvulsant level determination in the treatment of epilepsies].
    Loiseau P; Brachet-Liermain A; Legroux M; Jogeix M
    Nouv Presse Med; 1977 Mar; 6(10):813-7. PubMed ID: 322087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo interaction of anticonvulsant drugs. The mathematical correlation of plasma levels of anticonvulsant drugs in epileptic patients.
    Abarbanel J; Herishanu Y; Rosenberg P; Eylath U
    J Neurol; 1978 May; 218(2):137-44. PubMed ID: 78974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phenobarbital and diphenylhydantoin in the plasma and phenobarbital in the cerebrospinal fluid. I. Studies on the concurrent determination of phenobarbital and diphenylhydantoin in the plasma by ultraviolet spectrophotometry and its clinical application].
    Izumi N
    Nihon Shonika Gakkai Zasshi; 1970 May; 74(5):539-51. PubMed ID: 5464711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood levels of phenytoin and phenobarbital in epileptics treated with phenydantin and phenytoinum].
    Rosnowska M; Zieliński JJ; Szukalski B
    Neurol Neurochir Pol; 1978; 12(5):569-73. PubMed ID: 724029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of epileptics with phenobarbital and diphenylhydantoin in small doses versus separate treatment with large doses of either drug. A study of the clinical effects.
    Volanschi D; Pintilie C
    Neurol Psychiatr (Bucur); 1978; 16(4):259-69. PubMed ID: 741196
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of serum levels of phenobarbital and diphenylhydantoin in the treatment of epilepsy].
    Benetello P; Testa G; Furlanut M
    Clin Ter; 1978 Apr; 85(1):11-8. PubMed ID: 657740
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
    Borst SI; Lockwood CH
    Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):309-14. PubMed ID: 1242131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute primidone overdosage with massive crystalluria.
    Cate JC IV; Tenser R
    Clin Toxicol; 1975; 8(4):385-9. PubMed ID: 1220892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The necessity of drug level monitoring in anticonvulsant drug therapy.
    Davis HL; Bailey DG; Johnson GE; Wilson TW
    Can J Physiol Pharmacol; 1976 Dec; 54(6):850-8. PubMed ID: 1021220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of phenobarbital, mephenytoin and diphenylhydantoin in the surveillance of anticonvulsant treatment].
    Maitrot B; Hue G; Canonne MA; Rocher A; Landriau N
    Ann Biol Clin (Paris); 1976; 34(2):107-12. PubMed ID: 9890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma concentration of phenytoin in epileptics--importance for the clinician].
    Deonna T; de Crousaz G; Magrini G; Bechtel P; Schelling JL
    Schweiz Med Wochenschr; 1975 Jul; 105(30):936-41. PubMed ID: 1153992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children.
    Buchanan RA; Allen RJ
    Neurology; 1971 Aug; 21(8):866-71. PubMed ID: 5106302
    [No Abstract]   [Full Text] [Related]  

  • 16. [Investigations of serum levels of drugs in children receiving anticonvulsant medication. I. General evaluation of serum concentrations of diphenylhydantoin, primidone and phenobarbitone (author's transl)].
    Windorfer A; Gädeke R; Sauer M
    Z Kinderheilkd; 1975; 119(1):15-24. PubMed ID: 1124582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of diphenylhydantoin and phenobarbital in epileptic children receiving diphenylhydantoin, phenobarbital and-or mysoline.
    Yoshida T; Karahashi M; Tanabu M; Takagi T; Arakawa T
    Tohoku J Exp Med; 1974 Feb; 112(2):169-75. PubMed ID: 4836029
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological observations on plasma levels of diphenylhydantoin in 130 patients on prolonged treatment (author's tranls)].
    Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Visintini D; Calzetti S; Poloni M
    Riv Patol Nerv Ment; 1976; 97(5):305-14. PubMed ID: 1032214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum free levels and evaluation anticonvulsant drug interactions.
    Reynolds NC; Murthy VS
    Wis Med J; 1989 Dec; 88(12):25-7. PubMed ID: 2515661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations and efficacy of phenytoin, phenobarbital, and primidone in canine epilepsy.
    Farnbach GC
    J Am Vet Med Assoc; 1984 May; 184(9):1117-20. PubMed ID: 6725128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.